C
Genmab A/S GMAB
$31.94 $0.601.91% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2026 03/31/2026 06/30/2025 06/30/2025 06/30/2025
Net Income 471.70% 70.97% 72.31% 72.31% 72.31%
Total Depreciation and Amortization -15.79% 26.67% -25.00% 0.00% 0.00%
Total Amortization of Deferred Charges 17.24% 383.33% -- -- --
Total Other Non-Cash Items -333.33% 475.00% -18,600.00% -18,600.00% -18,600.00%
Change in Net Operating Assets -136.28% -144.66% -240.00% -240.00% -240.00%
Cash from Operations 1,600.00% -99.00% -78.40% -78.40% -78.40%
Capital Expenditure 60.00% 61.54% 16.67% 16.67% 16.67%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 200.00% -100.24% 216.13% 216.13% 216.13%
Cash from Investing 122.22% 99.84% 160.47% 160.47% 160.47%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 5.80% -3,350.00% -100.00% -100.00% -100.00%
Issuance of Common Stock -50.00% -71.43% 500.00% 500.00% 500.00%
Repurchase of Common Stock 91.82% -3,566.67% -3,300.00% -3,300.00% -3,300.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 57.63% -103.38% -3,023.08% -3,023.08% -3,023.08%
Foreign Exchange rate Adjustments 136.36% -175.00% -162.50% -162.50% -162.50%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 90.72% -321.74% -235.15% -235.15% -235.15%